Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 14 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Surrozen, Inc./DE | 999,429 | reported | 14 Jan 2026 | tx 4+17,993 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 24+393,236−21,743,413 |
| Tenaya Therapeutics, Inc. | 0 | reported | 25 Feb 2026 | tx 4−4,170,266 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Feb 2026 | SALE | Tenaya Therapeutics, Inc. | 1,649,281 | 0.56 USD | |
| 24 Feb 2026 | SALE | Tenaya Therapeutics, Inc. | 349,212 | 0.62 USD | |
| 25 Feb 2026 | SALE | Tenaya Therapeutics, Inc. | 1,862,545 | 0.56 USD | |
| 24 Feb 2026 | SALE | Tenaya Therapeutics, Inc. | 309,228 | 0.62 USD | |
| 13 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 5,861 | 19.80 USD | |
| 14 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 2,927 | 19.99 USD | |
| 14 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 2,596 | 19.99 USD | |
| 13 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 6,609 | 19.80 USD | first after silence |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 90,442 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 11,103,333 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 858,035 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 968,990 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 2,265,758 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,298,908 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,298,908 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 100,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 100,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 15,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 44,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 949,862 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 2,650,177 | — | |
| 31 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 176,730 | 5.00 USD | |
| 30 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 7,542 | 5.00 USD | |
| 19 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 37,639 | 5.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 13 Jan 2026.